1. Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer;Duque;Urology,1999
2. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480;George;Clin Cancer Res,2001
3. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer;Fox;Clin Cancer Res,2002
4. The use of bevacizumab with docetaxel and estramustine in hormone refractory prostate cancer (HRPC): Initial results of CALGB 90006;Picus;Proc Am Soc Clin Oncol,2003